Sudden Sensorineural Hearing Loss: Current Evidence of Etiology, Management, and Prognosis
Abstract
Sudden sensorineural hearing loss (SSNHL) is an otologic emergency because if not recognized and promptly treated, it can result in permanent hearing loss, tinnitus, and reduced quality of life. Although 70% of SSNHL cases are idiopathic, it is potentially linked to vascular impairment, especially migraines. Currently, there is a standard guideline from the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) for SSNHL. However, the effectiveness of treatment is still uncertain. Moreover, there are still knowledge gaps in many aspects of SSNHL, such as the lack of a standardized measurement for hearing improvement and the lack of a definite timeline for salvage therapy. In this review, the current evidence of etiology, management, and prognostic factors of SSNHL is elaborated.
Keywords
Full Text:
PDF (Early Version)References
Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg 2019;161:S1-45. PubMed
Rauch SD. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833-40.
Kitoh R, Nishio S, Ogawa K, Kanzaki S, Hato N, Sone M, et al. Nationwide epidemiological survey of idiopathic sudden sensorineural hearing loss in Japan. Acta Otolaryngol 2017;137:S8-16.
Chau JK, Lin JRJ, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010;120:1011-21.
Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss. Trends Amplif 2011;15:91-105.
Gündoğan F, Bayram A, Kalkan M, Özcan İ. Plasma levels of endothelial cell-specific molecule-1 and pentraxin-3 in idiopathic sudden sensorineural hearing loss. J Laryngol Otol 2018;132:995-9.
Mohammadi M, Hosein M, Rajabi A. Migraine and risk of sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope Investig Otolaryngol 2020;5:1089-95.
Piovesan EJ, Kowacs PA, Werneck LC, Siow C. Oscillucusis and sudden deafness in a migraine patient. Arq Neuropsiquiatr 2003;61:848-50. PubMed
Dash AK, Panda N, Khandelwal G, Lal V, Mann SS. Migraine and audiovestibular dysfunction: is there a correlation? Am J Otolaryngol 2008;29:295-9.
Lee H, Lopez I, Ishiyama A, Baloh RW. Can migraine damage the inner ear? Arch Neurol 2000;57:1631-4.
Wilson WR. The relationship of the herpesvirus family to sudden hearing loss: a prospective clinical study and literature review. Laryngoscope 1986;96:870-7.
Lin C, Lin SW, Weng SF, Lin YS. Increased risk of sudden sensorineural hearing loss in patients with human immunodeficiency virus aged 18 to 35 years. JAMA Otolaryngol Head Neck Surg 2013;139:251-5.
Berrocal G, Vargas JA, Vaquero M, Ramón y Cajal S, Ramírez-Camacho RA. Cogan's syndrome: an oculo-audiovestibular disease. Postgrad Med J 1999;75:262-4.
Kempf HG. Ear involvement in Wegener's granulomatosis. Clin Otolaryngol 1989;14:451-6.
Naarendorp M, Spiera H. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies. J Rheumatol 1998;25:2476-7.
Jeong KH, Choi JW, Shin JE, Kim CH. Abnormal magnetic resonance imaging findings in patients with sudden sensorineural hearing loss. Medicine (Baltimore) 2016;95:e3557.
Pensak ML, Glasscock ME 3rd, Josey AF, Jackson CG, Gulya AJ. Sudden hearing loss and cerebellopontine angle tumors. Laryngoscope 1985;95:1188-93.
Lee JD, Lee BD, Hwang SC. Vestibular schwannoma in patients with sudden sensorineural hearing loss. Skull Base 2011;21:75-8. PubMed
Schmidt RJ, Sataloff RT, Newman J, Spiegel JR, Myers DL. The sensitivity of auditory brainstem response testing for the diagnosis of acoustic neuromas. Arch Otolaryngol Head Neck Surg 2001;127:19-22.
Tsuzuki N, Wasano K. Idiopathic sudden sensorineural hearing loss: a review focused on the contribution of vascular pathologies. Auris Nasus Larynx 2024;51:747-54.
Gross ND, Kempton JB, Trune DR. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice. Laryngoscope 2002;112:298-303.
Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305:2071-9. PubMed
Swachia K, Sharma D, Singh J. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. J Basic Clin Physiol Pharmacol 2016;27:371-7. PubMed
Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013;7:CD003998.
Raghunandhan S, Agarwal AK, Natarajan K, Murali S, Anand Kumar RS, Kameswaran M. Effect of intravenous administration of steroids in the management of sudden sensori-neural hearing loss: our experience. Indian J Otolaryngol Head Neck Surg 2013;65:229-33. PubMed
Gupta S, Gyawali BR, Pradhananga RB, Rayamajhi P. Role of short course intravenous methylprednisolone in the management of sudden sensorineural hearing loss. Int J Otorhinolaryngol Head Neck Surg 2021;7:217.
Eftekharian A, Amizadeh M. Pulse steroid therapy in idiopathic sudden sensorineural hearing loss: a randomized controlled clinical trial. Laryngoscope 2016;126:150-5.
Plontke SK, Meisner C, Agrawal S, Cayé-Thomasen P, Galbraith K, Mikulec AA, et al. Intratympanic corticosteroids for sudden sensorineural hearing loss. Cochrane Database Syst Rev 2022;7:CD008080.
Lee HA, Chung JH. Contemporary review of idiopathic sudden sensorineural hearing loss: management and prognosis. J Audiol Otol 2024;28:10-7. PubMed
Ho GM, Lin HC, Shu MT, Yang CC, Tsai HT. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 2004;114:1184-9. PubMed
Xenellis J, Papadimitriou NI, Nikolopoulos TP, Maragoudakis P, Segas JV, Tzagaroulakis A, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940-5.
Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009;119:359-69.
Lee JB, Choi SJ, Park K, Park HS, Choo OS, Choung YH. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2011;268:833-9.
Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol 2011;16:198-202.
Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss. Otol Neurotol 2011;32:774-9.
Zhou Y, Zheng H, Zhang Q, Campione PA. Early transtympanic steroid injection in patients with "poor prognosis" idiopathic sensorineural sudden hearing loss. ORL J Otorhinolaryngol Relat Spec 2011;73:31-7.
Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004;97:385-95.
Khater A, El-Anwar M, Nofal A, Elbahrawy A. Sudden sensorineural hearing loss: comparative study of different treatment modalities. Int Arch Otorhinolaryngol 2018;22:245-9. PubMed
Chi TH, Chiang MC, Chen RF, Yuan CH. Does the addition of hyperbaric oxygen therapy to conventional treatment modalities influence the outcome of soldiers with idiopathic sudden sensorineural hearing loss? J R Army Med Corps 2018;164:69-71.
Cho I, Lee HM, Choi SW, Kong SK, Lee IW, Goh EK, et al. Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Audiol Neurootol 2018;23:199-207.
Krajčovičová Z, Meluš V, Zigo R, Matišáková I, Večeřa J, Kašlíková K. Efficacy of hyperbaric oxygen therapy as a supplementary therapy of sudden sensorineural hearing loss in the Slovak Republic. Undersea Hyperb Med 2018;45:363-70.
Huang C, Tan G, Xiao J, Wang G. Efficacy of hyperbaric oxygen on idiopathic sudden sensorineural hearing loss and its correlation with treatment course: prospective clinical research. Audiol Neurootol 2021;26:479-86. PubMed
Dova S, Psillas G, Tsaligopoulos M, Nikolaidis V, Stefanidou S, Karagiannis G, et al. The effectiveness of hyperbaric oxygen therapy on the final outcome of patients with sudden sensorineural hearing loss. Am J Otolaryngol 2022;43:103564.
Rhee TM, Hwang D, Lee JS, Park J, Lee JM. Addition of hyperbaric oxygen therapy vs medical therapy alone for idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 2018;144:1153-61. PubMed
Yang CH, Wu RW, Hwang CF. Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss. Otol Neurotol 2013;34:1411-6.
Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol 2013;34:1021-6.
Gülüstan F, Yazıcı ZM, Alakhras WME, Erdur O, Acipayam H, Kufeciler L, et al. Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss. Braz J Otorhinolaryngol 2018;84:28-33.
Sun H, Qiu X, Hu J, Ma Z. Comparison of intratympanic dexamethasone therapy and hyperbaric oxygen therapy for the salvage treatment of refractory high-frequency sudden sensorineural hearing loss. Am J Otolaryngol 2018;39:531-5.
Almosnino G, Holm JR, Schwartz SR, Zeitler DM. The role of hyperbaric oxygen as salvage therapy for sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 2018;127:672-6.
Sun Y, Wang S, Fu H, Ge X, Pan S. Hyperbaric oxygen therapy for sudden sensorineural hearing loss (review). Mol Med Rep 2025;32:307. PubMed
Lei X, Feng Y, Xia L, Sun C. Hyperbaric oxygen therapy versus intratympanic steroid for salvage treatment of sudden sensorineural hearing loss. Otol Neurotol 2021;42:980-6.
Awad Z, Huins C, Pothier DD. Antivirals for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2012;8:CD006987.
Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2009;4:CD003422.
Kang HS, Park JJ, Ahn SK, Hur DG, Kim HY. Effect of high dose intravenous vitamin C on idiopathic sudden sensorineural hearing loss: a prospective single-blind randomized controlled trial. Eur Arch Otorhinolaryngol 2013;270:2631-6.
Kaya H, Koç AK, Sayın İ, Güneş S, Altıntaş A, Yeğin Y, et al. Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2015;272:1119-25.
Ibrahim I, Zeitouni A, da Silva SD. Effect of antioxidant vitamins as adjuvant therapy for sudden sensorineural hearing loss: systematic review study. Audiol Neurootol 2018;23:1-7.
Yang CH, Ko MT, Peng JP, Hwang CF. Zinc in the treatment of idiopathic sudden sensorineural hearing loss. Laryngoscope 2011;121:617-21.
Hunchaisri N, Chantapant S, Sirirattanapan J. Effectiveness of oral zinc supplementation in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL). J Med Assoc Thai 2015;98:400-7.
Wang Q, Liu Y, Guo X. Correlation between oral zinc sulfate supplementation and auditory recovery in patients with sudden sensorineural hearing loss. Pak J Pharm Sci 2024;37:1475-84.
Angeli SI, Abi-Hachem RN, Vivero RJ, Telischi FT, Machado JJ. L-N-acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. Acta Otolaryngol 2012;132:369-76.
Chen CH, Young YH. N-acetylcysteine as a single therapy for sudden deafness. Acta Otolaryngol 2017;137:58-62.
Koo JW, Chang MS, Yun SC, Kim TS, Kong SK, Chung JW, et al. The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial. Eur Arch Otorhinolaryngol 2016;273:2433-41.
Si X, Yu Z, Ren X, Huang L, Feng Y. Efficacy and safety of standardized Ginkgo biloba L. leaves extract as an adjuvant therapy for sudden sensorineural hearing loss: a systematic review and meta-analysis. J Ethnopharmacol 2022;282:114587.
Chiossoine-Kerdel JA, Baguley DM, Stoddart RL, Moffat DA. An investigation of the audiologic handicap associated with unilateral sudden sensorineural hearing loss. Am J Otol 2000;21:645-51.
Abouzari M, Goshtasbi K, Chua JT, Tan D, Sarna B, Saber T, et al. Adjuvant migraine medications in the treatment of sudden sensorineural hearing loss. Laryngoscope 2021;131:E283-8.
Goshtasbi K, Chua JT, Risbud A, Sarna B, Jamshidi S, Abouzari M, et al. Treatment of long-term sudden sensorineural hearing loss as an otologic migraine phenomenon. Otol Neurotol 2021;42:1001-7.
Ballesteros F, Alobid I, Tassies D, Reverter JC, Scharf RE, Guilemany JM, et al. Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors? Audiol Neurootol 2009;14:139-45.
Hakuba N, Koga K, Shudou M, Watanabe F, Mitani A, Gyo K. Hearing loss and glutamate efflux in the perilymph following transient hindbrain ischemia in gerbils. J Comp Neurol 2000;418:217-26.
Hakuba N, Matsubara A, Hyodo J, Taniguchi M, Maetani T, Shimizu Y, et al. AMPA/kainate-type glutamate receptor antagonist reduces progressive inner hair cell loss after transient cochlear ischemia. Brain Res 2003;979:194-202.
Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80.
Chaushu H, Ungar OJ, Abu Eta R, Handzel O, Muhanna N, Oron Y. Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Clin Otolaryngol 2023;48:395-402.
Ha YR, Kim D, Kim SS, Lee JM, Kim SH, Yeo SG. Comparison of recovery rates of sudden sensorineural hearing loss by age group. J Clin Med 2024;13:4937.
Byl FM. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984;94:647-61.
Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529-36.
Xenellis J, Karapatsas I, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Tzagkaroulakis M, et al. Idiopathic sudden sensorineural hearing loss: prognostic factors. J Laryngol Otol 2006;120:718-24. PubMed
Na SY, Kim MG, Hong SM, Chung JH, Kang HM, Yeo SG. Comparison of sudden deafness in adults and children. Clin Exp Otorhinolaryngol 2014;7:165-9.
Chung JH, Cho SH, Jeong JH, Park CW, Lee SH. Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss in children. Laryngoscope 2015;125:2209-15.
Kim JY, Han JJ, Sunwoo WS, Koo JW, Oh SH, Park MH, et al. Sudden sensorineural hearing loss in children and adolescents: clinical characteristics and age-related prognosis. Auris Nasus Larynx 2018;45:447-55.
Lu Y, Zhou L, Imrit TS, Liu A. Sudden sensorineural hearing loss in children. Otol Neurotol 2019;40:446-53.
Reading JCS, Hall A, Nash R. Paediatric sudden sensorineural hearing loss: pooled analysis and systematic review. J Int Adv Otol 2021;17:64-71.
Guan R, Zhao Z, Guo X, Sun J. The semicircular canal function tests contribute to identifying unilateral idiopathic sudden sensorineural hearing loss with vertigo. Am J Otolaryngol 2020;41:102461.
Cadoni G, Rizzuti A, Sollazzo M, Picciotti PM, Galli J. Audiogram shape: does it have a significant prognostic role in idiopathic sudden sensorineural hearing loss outcome? J Pers Med 2025;15:379. PubMed
Diao T, Chen Y, Jing Y, Ma X. Clinical characteristics and prognosis of acute low-frequency hearing loss and ascending sensorineural sudden sensorineural hearing loss. Front Neurosci 2022;16:1076109. PubMed
Toroslu T, Erdogan H, Caglar O, Guclu O, Derekoy FS. Comparison of different treatment methods for idiopathic sudden sensorineural hearing loss. Turk Arch Otorhinolaryngol 2018;56:226-32.
Chen I, Eligal S, Menahem O, Salem R, Sichel JY, Perez R, et al. Time from sudden sensory neural hearing loss to treatment as a prognostic factor. Front Neurol 2023;14:1158955. PubMed
Ulu S, Ulu MS, Bucak A, Ahsen A, Yucedag F, Aycicek A. Neutrophil-to-lymphocyte ratio as a new, quick, and reliable indicator for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2013;34:1400-4.
Chen L, Zhang G, Zhang Z, Wang Y, Hu L, Wu J. Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Medicine (Baltimore) 2018;97:e12492.
Huang X, Ni X, Shen J, Chen L, Xu L, Tang X. Associations between neutrophil-to-lymphocyte/platelet-to-lymphocyte and recovery in sudden sensorineural hearing loss. Biomark Med 2024;18:115-22.
Niknazar S, Bazgir N, Shafaei V, Abbaszadeh HA, Zali A, Peyvandi AA. Assessment of prognostic biomarkers in sudden sensorineural hearing loss: a systematic review and meta-analysis. Clin Biochem 2023;121-122:110684.
Cao Z, Li Z, Xiang H, Huang S, Gao J, Zhan X, et al. Prognostic role of haematological indices in sudden sensorineural hearing loss: review and meta-analysis. Clin Chim Acta 2018;483:104-11.
Frosolini A, Franz L, Daloiso A, Lovato A, de Filippis C, Marioni G. Digging into the role of inflammatory biomarkers in sudden sensorineural hearing loss diagnosis and prognosis: a systematic review and meta-analysis. Medicina (Kaunas) 2022;58:963.
Chen L, Wang M, Zhang W, Zhang X, Jiao C, Yu Y, et al. The value of inflammatory biomarkers in the occurrence and prognosis of sudden sensorineural hearing loss: a meta-analysis. Eur Arch Otorhinolaryngol 2023;280:3119-29.
Jung SY, Shim HS, Hah YM, Kim SH, Yeo SG. Association of metabolic syndrome with sudden sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg 2018;144:308-14.
Lam M, Bao Y, Hua GB, Sommer DD. Sudden sensorineural hearing loss and metabolic syndrome: a systematic review and meta-analysis. Otol Neurotol 2021;42:1308-13.
Park JS, Kim SH, Kim I, Kim H, Kim JH, Lee JB. Does metabolic syndrome affect the incidence and prognosis of sudden sensorineural hearing loss? Life (Basel) 2022;12:930.
Papadopoulou AM, Papouliakos S, Karkos P, Chaidas K. The impact of cardiovascular risk factors on the incidence, severity, and prognosis of sudden sensorineural hearing loss (SSHL): a systematic review. Cureus 2024;16:e58377.
Ryu OH, Choi MG, Park CH, Kim DK, Lee JS, Lee JH. Hyperglycemia as a potential prognostic factor of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2014;150:853-8.
Lin CF, Lee KJ, Yu SS, Lin YS. Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss. Laryngoscope 2016;126:142-9.
Quaranta N, Squeo V, Sangineto M, Graziano G, Sabbà C. High total cholesterol in peripheral blood correlates with poorer hearing recovery in idiopathic sudden sensorineural hearing loss. PLoS One 2015;10:e0133300.
Shao M, Xiong G, Xiang G, Xu S, Zhang L. Correlation between serum lipid and prognosis of idiopathic sudden sensorineural hearing loss: a prospective cohort study. Ann Transl Med 2021;9:676.
Li J, Zhu YM, Wang YQ, Gu XC. Associations of blood lipids with the risk and prognosis of sudden sensorineural hearing loss: a meta-analysis. J Int Adv Otol 2024;20:431-8.
Lin HC, Wang CH, Chou YC, Shih CP, Chu YH, Lee JC, et al. The correlation between lipoprotein ratios and hearing outcome in idiopathic sudden sensorineural hearing loss patients. Clin Otolaryngol 2015;40:355-62.
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.